Common genetic variants in sex hormone pathway genes and papillary thyroid cancer risk

Thyroid

Volumn 22, Issue 2, 2012, Pages 151-156

  Schonfeld, Sara J ^a   Neta, Gila ^a   Sturgis, Erich M ^b   Pfeiffer, Ruth M ^a   Hutchinson, Amy A ^a,c   Xu, Li ^b   Wheeler, William ^d   Guénel, Pascal ^e,f   Rajaraman, Preetha ^a   De Vathaire, Florent ^f,g,h   Ron, Elaine ^a   Tucker, Margaret A ^a   Chanock, Stephen J ^a   Sigurdson, Alice J ^a   Brenner, Alina V ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SAIC FREDERICK INC   (United States)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f UNIVERSITÉ PARIS SACLAY   (France)

^g INSERM   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; PROLACTIN; SEX HORMONE;

ADULT; AGED; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID PAPILLARY CARCINOMA;

ADULT; AGED; AROMATASE; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GONADAL STEROID HORMONES; GONADOTROPINS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROLACTIN; RISK; SEX FACTORS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84863016766     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0309     Document Type: Review

References (19)

1. Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, Devesa SS, McGlynn KA 2009 Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 18:1174-1182.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM 2010 GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 Internet. International Agency for Research on Cancer, Lyon, France.
3. Kilfoy BA, Devesa SS, Ward MH, Zhang Y, Rosenberg PS, Holford TR, Anderson WF 2009 Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev 18:1092-1100.
4. Chen GG, Vlantis AC, Zeng Q, van Hasselt CA 2008 Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer. Curr Cancer Drug Targets 8:367-377.
5. Rahbari R, Zhang L, Kebebew E 2010 Thyroid cancer gender disparity. Future Oncol 6:1771-1779.
6. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S 2009 Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 20: 75-86.
7. Wang SS, Gonzalez P, Yu K, Porras C, Li Q, Safaeian M, Rodriguez AC, Sherman ME, Bratti C, Schiffman M, Wa-cholder S, Burk RD, Herrero R, Chanock SJ, Hildesheim A 2010 Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One 5:e8667.
8. Yang HP, Gonzalez Bosquet J, Li Q, Platz EA, Brinton LA, Sherman ME, Lacey JV Jr, Gaudet MM, Burdette LA, Fig-ueroa JD, Ciampa JG, Lissowska J, Peplonska B, Chanock SJ, Garcia-Closas M 2010 Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. Carcinogen-esis 31:827-833.
9. Neta G, Brenner AV, Sturgis EM, Pfeiffer RM, Hutchinson A, Aschebrook-Kilfoy B, Yeager M, Xu L, Wheeler W, Abend M, Ron E, Tucker MA, Chanock SJ, Sigurdson AJ 2011 Common genetic variants related to genomic integrity and risk of papillary thyroid cancer. Carcinogenesis 32:1231-1237.
10. Sigurdson AJ, Doody MM, Rao RS, Freedman DM, Alexander BH, Hauptmann M, Mohan AK, Yoshinaga S, Hill DA, Tarone R, Mabuchi K, Ron E, Linet MS 2003 Cancer incidence in the US radiologic technologists health study, 1983-1998. Cancer 97:3080-3089. (Pubitemid 36676264)
11. Ho T, Li G, Lu J, Zhao C, Wei Q, Sturgis EM 2009 Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid 19: 129-135.
12. Lönn S, Bhatti P, Alexander B, Pineda M, Doody M, Struewing J, Sigurdson A 2007 Papillary thyroid cancer and polymorphic variants in TSHR-and RET-related genes: a nested case-control study within a cohort of US radiologic technologists. Cancer Epidemiol Biomarkers Prev 16: 174-177. (Pubitemid 46174283)
13. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464.
14. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, Takigawa-Imamura H, Akulevich NM, Ratanajaraya C, Mitsutake N, Takamura N, Danilova LI, Lushchik ML, Demidchik YE, Heath S, Yamada R, Lathrop M, Matsuda F, Yamashita S 2010 The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 19: 2516-2523.
15. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA 2004 Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74:106-120. (Pubitemid 38085242)
16. Benjamini Y, Hochberg Y 1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Methodological) 57:289-300.
17. Yu K, Li Q, Bergen AW, Pfeiffer RM, Rosenberg PS, Ca-poraso N, Kraft P, Chatterjee N 2009 Pathway analysis by adaptive combination of P-values. Genet Epidemiol 33:700-709.
18. Rebai M, Kallel I, Charfeddine S, Hamza F, Guermazi F, Rebai A 2009 Association of polymorphisms in estrogen and thyroid hormone receptors with thyroid cancer risk. J Recept Signal Transduct Res 29:113-118.
19. Adjadj E, Schlumberger M, de Vathaire F 2009 Germ-line DNA polymorphisms and susceptibility to differentiated thyroid cancer. Lancet Oncol 10:181-190.